Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit

• 收藏
• 分享

专利权人:

Cipla Limited

发明人:

Malhotra, Geena,Lulla, Amar

申请号：

AU2006325404

公开号：

AU2006325404B2

申请日:

2006.12.14

申请国别(地区):

AU

年份:

2012

代理人:

摘要：

A pharmaceutical formulation for the treatment of HIV is provided. The formulation is a combination of a nucleoside reverse transcriptase inhibitor and a nucleotide reverse transcriptase inhibitor in which the combination has an increased stability over prior, art combination therapies. The invention also provides a pharmaceutical product containing the formulation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/